Previously, Kenvue and Shenzhen Nepstar have been cooperating in the over-the-counter (OTC) drug field in China for many ...

Analysts split on whether Kenvue's (KVUE) reinvestment in Neutrogena could lead to market share gains. Read more here.

Fintel reports that on September 24, 2024, Jefferies initiated coverage of Kenvue (NYSE:KVUE) with a Buy recommendation. ...

Fintel reports that on September 24, 2024, RBC Capital downgraded their outlook for Kenvue (NYSE:KVUE) from Outperform to ...

We recently compiled a list of the 10 Best Household and Personal Care Stocks to Buy. In this article, we are going to take a ...

Kenvue Inc. (NYSE: KVUE) is releasing its first Task Force on Climate-related Financial Disclosures (TCFD) report.

On Monday, Kenvue Inc (KVUE) stock saw a modest uptick, ending the day at $23.02 which represents no change from the prior close of $23.02. The stock opened at $22.83 and touched a low of $22.76 ...

In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report), with ...

Kenvue, the consumer health company that markets brands such as Tylenol, Neutrogena and Listerine, has launched a global ...

THE WHAT?  Kenvue has officially launched Aveeno® in 12 Central European markets, marking a significant milestone in the ...

First Task Force on Climate-related Financial Disclosures (TCFD) report enhances transparency and accountabilityCompany advances sustainability across ...

RBC Capital Markets analysts downgraded Kenvue (NYSE: KVUE) stock on Tuesday, citing challenges in the company's Skin Health & Beauty segment, particularly with its Neutrogena bra ...